Trial intelligence / Profile preview

INNOVATE real-world effectiveness study of glecaprevir + pibrentasvir in chronic hepatitis C

MOH_2017-10-24_001874Phase 4Completed

Sponsor

AbbVie Inc.

Start

Oct 2017

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1